<VariationArchive VariationID="554004" VariationName="NM_000091.5(COL4A3):c.345del (p.Pro116fs)" VariationType="Deletion" Accession="VCV000554004" Version="16" RecordType="classified" NumberOfSubmissions="8" NumberOfSubmitters="8" DateLastUpdated="2024-06-23" DateCreated="2018-08-05" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="542004" VariationID="554004">
      <GeneList>
        <Gene Symbol="COL4A3" FullName="collagen type IV alpha 3 chain" GeneID="1285" HGNC_ID="HGNC:2204" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q36.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="227164624" stop="227314792" display_start="227164624" display_stop="227314792" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="228029280" stop="228179507" display_start="228029280" display_stop="228179507" Strand="+" />
          </Location>
          <OMIM>120070</OMIM>
        </Gene>
        <Gene Symbol="MFF-DT" FullName="MFF divergent transcript" GeneID="654841" HGNC_ID="HGNC:41067" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q36.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="227221052" stop="227325164" display_start="227221052" display_stop="227325164" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000091.5(COL4A3):c.345del (p.Pro116fs)</Name>
      <CanonicalSPDI>NC_000002.12:227245971:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q36.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="227245972" stop="227245972" display_start="227245972" display_stop="227245972" variantLength="1" positionVCF="227245971" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="228110688" stop="228110688" display_start="228110688" display_stop="228110688" variantLength="1" positionVCF="228110687" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>P116fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.228110690del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.228110690del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.227245974del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.227245974del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011591.1" sequenceAccession="NG_011591" sequenceVersion="1" change="g.86410del">
            <Expression>NG_011591.1:g.86410del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000091.5" sequenceAccession="NM_000091" sequenceVersion="5" change="c.345del" MANESelect="true">
            <Expression>NM_000091.5:c.345del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000082.2" sequenceAccession="NP_000082" sequenceVersion="2" change="p.Pro116fs">
            <Expression>NP_000082.2:p.Pro116fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000091.4" sequenceAccession="NM_000091" sequenceVersion="4" change="c.345delG">
            <Expression>NM_000091.4:c.345delG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_230" sequenceAccession="LRG_230">
            <Expression>LRG_230:g.86410del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_230t1" sequenceAccession="LRG_230t1">
            <Expression>LRG_230t1:c.345del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_230p1" sequenceAccession="LRG_230p1" change="p.Pro116fs">
            <Expression>LRG_230p1:p.Pro116fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="749390823" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000091.5(COL4A3):c.345del (p.Pro116fs) AND Autosomal recessive Alport syndrome" Accession="RCV000669553" Version="4">
        <ClassifiedConditionList TraitSetID="5721">
          <ClassifiedCondition DB="MedGen" ID="C4746745">Autosomal recessive Alport syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2020-06-03" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000091.5(COL4A3):c.345del (p.Pro116fs) AND not provided" Accession="RCV001061377" Version="12">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-24" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000091.5(COL4A3):c.345del (p.Pro116fs) AND Alport syndrome" Accession="RCV001272223" Version="2">
        <ClassifiedConditionList TraitSetID="6750">
          <ClassifiedCondition DB="MedGen" ID="C1567741">Alport syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-09-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000091.5(COL4A3):c.345del (p.Pro116fs) AND Autosomal dominant Alport syndrome" Accession="RCV001281228" Version="3">
        <ClassifiedConditionList TraitSetID="5740">
          <ClassifiedCondition DB="MedGen" ID="C5882663">Autosomal dominant Alport syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-24" NumberOfSubmissions="8" NumberOfSubmitters="8" DateCreated="2018-08-05" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24854265</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25450602</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26277931</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26809805</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27281700</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32860008</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33532864</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8956999</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5721" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="282" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Alport syndrome recessive type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nephropathy and deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">COL4A4 Alport Syndrome and Thin Basement Membrane Nephropathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="203780" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive Alport syndrome</ElementValue>
                <XRef ID="MONDO:0008762" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ATS2</ElementValue>
                <XRef Type="MIM" ID="203780" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">COL4A3-Related Nephropathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">COL4A4-Related Nephropathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">In Alport syndrome (AS) a spectrum of phenotypes ranging from progressive renal disease with extrarenal abnormalities to isolated hematuria with a non-progressive or very slowly progressive course is observed. Approximately two thirds of AS is X-linked (XLAS); approximately 15% is autosomal recessive (ARAS), and approximately 20% is autosomal dominant (ADAS). In the absence of treatment, renal disease progresses from microscopic hematuria (microhematuria) to proteinuria, progressive renal insufficiency, and end-stage renal disease (ESRD) in all males with XLAS, and in all males and females with ARAS. Progressive sensorineural hearing loss (SNHL) is usually present by late childhood or early adolescence. Ocular findings include anterior lenticonus (which is virtually pathognomonic), maculopathy (whitish or yellowish flecks or granulations in the perimacular region), corneal endothelial vesicles (posterior polymorphous dystrophy), and recurrent corneal erosion. In individuals with ADAS, ESRD is frequently delayed until later adulthood, SNHL is relatively late in onset, and ocular involvement is rare.</Attribute>
                <XRef ID="NBK1207" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="625" />
                <XRef ID="625" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301386</ID>
                <ID Source="BookShelf">NBK1207</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">22166944</ID>
              </Citation>
              <XRef ID="63" DB="Orphanet" />
              <XRef ID="88919" DB="Orphanet" />
              <XRef ID="C4746745" DB="MedGen" />
              <XRef ID="MONDO:0008762" DB="MONDO" />
              <XRef Type="MIM" ID="203780" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6750" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="13255" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Alport syndrome</ElementValue>
                <XRef ID="MONDO:0018965" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS301050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hemorrhagic familial nephritis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hemorrhagic hereditary nephritis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital hereditary hematuria</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5785" />
                <XRef ID="5785" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="63" DB="Orphanet" />
              <XRef ID="C1567741" DB="MedGen" />
              <XRef ID="MONDO:0018965" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS301050" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5740" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="158" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Alport syndrome dominant type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Renal failure and sensorineural hearing loss</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant Alport syndrome</ElementValue>
                <XRef ID="MONDO:0007086" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alport syndrome 3, autosomal dominant</ElementValue>
                <XRef ID="Alport+Syndrome+Dominant+Type/336" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALPORT SYNDROME 3A, AUTOSOMAL DOMINANT</ElementValue>
                <XRef Type="MIM" ID="104200" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ATS3A</ElementValue>
                <XRef Type="MIM" ID="104200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">In Alport syndrome (AS) a spectrum of phenotypes ranging from progressive renal disease with extrarenal abnormalities to isolated hematuria with a non-progressive or very slowly progressive course is observed. Approximately two thirds of AS is X-linked (XLAS); approximately 15% is autosomal recessive (ARAS), and approximately 20% is autosomal dominant (ADAS). In the absence of treatment, renal disease progresses from microscopic hematuria (microhematuria) to proteinuria, progressive renal insufficiency, and end-stage renal disease (ESRD) in all males with XLAS, and in all males and females with ARAS. Progressive sensorineural hearing loss (SNHL) is usually present by late childhood or early adolescence. Ocular findings include anterior lenticonus (which is virtually pathognomonic), maculopathy (whitish or yellowish flecks or granulations in the perimacular region), corneal endothelial vesicles (posterior polymorphous dystrophy), and recurrent corneal erosion. In individuals with ADAS, ESRD is frequently delayed until later adulthood, SNHL is relatively late in onset, and ocular involvement is rare.</Attribute>
                <XRef ID="NBK1207" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="624" />
                <XRef ID="624" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301386</ID>
                <ID Source="BookShelf">NBK1207</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">22166944</ID>
              </Citation>
              <XRef ID="63" DB="Orphanet" />
              <XRef ID="88918" DB="Orphanet" />
              <XRef ID="C5882663" DB="MedGen" />
              <XRef ID="MONDO:0007086" DB="MONDO" />
              <XRef Type="MIM" ID="104200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1544618" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="647460|OMIM:203780" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000794315" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-09-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24854265</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="C" referenceAllele="CG" start="228110687" stop="228110688" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000091.4:c.345delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="203780" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2705165" SubmissionDate="2020-07-09" DateLastUpdated="2020-07-16" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="NM_000091.4:c.345delG|MedGen:C1567744" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001372412" DateUpdated="2020-07-16" DateCreated="2020-07-16" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25450602</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24854265</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26277931</ID>
          </Citation>
          <Comment>Variant summary: COL4A3 c.345delG (p.Pro116LeufsX37) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 3.6e-05 in 249432 control chromosomes. c.345delG has been reported in the literature in multiple individuals affected with Alport Syndrome, Autosomal Recessive (e.g. Moriniere_2014) or Autosomal Dominant (e.g. Rosado_2015). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Both laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000091.4:c.345delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Alport syndrome autosomal recessive</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1567744" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7746677</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2815333" SubmissionDate="2020-08-05" DateLastUpdated="2020-08-08" DateCreated="2020-08-08">
        <ClinVarSubmissionID localKey="NM_000091.3:c.345del|OMIM:203780" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001426555" DateUpdated="2020-08-08" DateCreated="2020-08-08" Type="SCV" Version="1" SubmitterName="Centogene AG  - the Rare Disease Company" OrgID="279559" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000091.3:c.345del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="203780" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">32860008</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB7885670</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2813840" SubmissionDate="2020-07-10" DateLastUpdated="2021-01-17" DateCreated="2021-01-17">
        <ClinVarSubmissionID localKey="NM_000091.5:c.345del|OMIM:104200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001425003" DateUpdated="2021-01-17" DateCreated="2021-01-17" Type="SCV" Version="1" SubmitterName="Molecular Biology Laboratory, Fundació Puigvert" OrgID="507661" OrganizationCategory="laboratory" OrgAbbreviation="Lab BM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">33532864</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000091.5:c.345del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="104200" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">33532864</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33532864</ID>
        </Citation>
        <StudyName>KidneyPanel_2020</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB7750420</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2869273" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_000091.4:c.345delG|Alport syndrome" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001453998" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000091.4:c.345delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Alport syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4897874" SubmissionDate="2022-11-30" DateLastUpdated="2022-12-03" DateCreated="2022-04-29">
        <ClinVarSubmissionID localKey="GDXSV:250188" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002504224" DateUpdated="2022-12-03" DateCreated="2022-04-29" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Reported in heterozygous state in two patients belonging to a single family with bilateral hearing loss and renal disease in published literature (Rosado et al., 2015); of note, several additional family members were noted only to have hearing loss; Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 33532864, 33353754, 31589614, 25450602, 24854265, 29246570, 32860008, 26277931)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A3" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:747522</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000091.4:c.345del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_103_20220427054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_143_20221123054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_147_20221130054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3962651" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="988b0d7d977362b8335e1d181363f0f744a6a8abe5ac6f37b8daa1cf885ef1a2|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002017460" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000091.5:c.345del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2391628" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4839183|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001226117" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8956999</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24854265</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26809805</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27281700</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24854265</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26277931</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro116Leufs*37) in the COL4A3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL4A3 are known to be pathogenic (PMID: 8956999, 24854265, 26809805, 27281700). This variant is present in population databases (rs749390823, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with clinical features of COL4A3-related conditions (PMID: 24854265, 26277931). ClinVar contains an entry for this variant (Variation ID: 554004). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.228110688del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1544618" TraitType="Disease" MappingType="XRef" MappingValue="203780" MappingRef="OMIM">
        <MedGen CUI="C4746745" Name="Autosomal recessive Alport syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2815333" TraitType="Disease" MappingType="XRef" MappingValue="203780" MappingRef="OMIM">
        <MedGen CUI="C4746745" Name="Autosomal recessive Alport syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3962651" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4897874" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2705165" TraitType="Disease" MappingType="Name" MappingValue="Alport syndrome autosomal recessive" MappingRef="Preferred">
        <MedGen CUI="C4746745" Name="Autosomal recessive Alport syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2869273" TraitType="Disease" MappingType="Name" MappingValue="Alport syndrome" MappingRef="Preferred">
        <MedGen CUI="C1567741" Name="Alport syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2391628" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2813840" TraitType="Disease" MappingType="XRef" MappingValue="104200" MappingRef="OMIM">
        <MedGen CUI="C5882663" Name="Autosomal dominant Alport syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

